CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Harbin Gloria Pharmaceuticals Co., Ltd Company Snapshot
Harbin Gloria Pharmaceuticals Co., Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Harbin Gloria Pharmaceuticals Co., Ltd with three other companies in this sector in China: Jiangsu Kanion Pharmaceutical Co., Ltd. (2016 sales of 3.00 billion Chinese Renmimbi [US$444.34 million] of which 100% was Exportation Trade), Guangdong Taiantang Pharmaceutical Co Ltd (3.07 billion Chinese Renmimbi [US$455.33 million] ), and Zhuzhou Qianjin Pharmaceutical Co., Ltd. (2.86 billion Chinese Renmimbi [US$424.20 million] of which 54% was Medicine Manufacturing).

Sales Analysis. Harbin Gloria Pharmaceuticals Co., Ltd reported sales of 2.98 billion Chinese Renmimbi (US$441.80 million) for the year ending December of 2016. This represents an increase of 10.5% versus 2015, when the company's sales were 2.70 billion Chinese Renmimbi. Sales at Harbin Gloria Pharmaceuticals Co., Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 446%). Sales of Other Operation saw an increase that was more than double the company's growth rate: sales were up 197.2% in 2016, from 16.51 million Chinese Renmimbi to 49.06 million Chinese Renmimbi. Harbin Gloria Pharmaceuticals Co., Ltd also saw significant increases in sales in Pharmaceutical Agents (up 61.3% to 578.50 million Chinese Renmimbi) and Pharmaceutical Research and Clinical Servi (up 35.3% to 47.50 million Chinese Renmimbi) and Financial Service (up 136.9% to 5.02 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Harbin Gloria Pharmaceuticals Co., Ltd
  Stock Performance Chart for Harbin Gloria Pharmaceuticals Co., Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 6.72
(Figures in Chinese Renmimbi)
1 Week -2.3%   13 Weeks 0.4%  
4 Weeks -13.3%   52 Weeks -21.4%  
 
Harbin Gloria Pharmaceuticals Co., Ltd Key Data:
  Ticker: 002437 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,983,142,424
(Year Ending Jan 2017).
Employees: 3,017
  Currency: Chinese Renmimbi Market Cap: 14,772,511,152
  Fiscal Yr Ends: December Shares Outstanding: 2,198,290,350
  Share Type: A Gu Closely Held Shares: 1,522,326,636
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.